- Home
- ATOS vs BFIN Comparison
ATOS vs BFIN Comparison
Compare ATOS & BFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOS
- BFIN
- Stock Information
- Founded
- ATOS 2009
- BFIN 1924
- Country
- ATOS United States
- BFIN United States
- Employees
- ATOS N/A
- BFIN N/A
- Industry
- ATOS Biotechnology: Pharmaceutical Preparations
- BFIN Savings Institutions
- Sector
- ATOS Health Care
- BFIN Finance
- Exchange
- ATOS Nasdaq
- BFIN Nasdaq
- Market Cap
- ATOS 174.8M
- BFIN 149.3M
- IPO Year
- ATOS 2012
- BFIN N/A
- Fundamental
- Price
- ATOS $1.47
- BFIN $11.94
- Analyst Decision
- ATOS Strong Buy
- BFIN
- Analyst Count
- ATOS 3
- BFIN 0
- Target Price
- ATOS $6.25
- BFIN N/A
- AVG Volume (30 Days)
- ATOS 575.2K
- BFIN 10.4K
- Earning Date
- ATOS 11-12-2024
- BFIN 10-28-2024
- Dividend Yield
- ATOS N/A
- BFIN 3.40%
- EPS Growth
- ATOS N/A
- BFIN N/A
- EPS
- ATOS N/A
- BFIN 0.66
- Revenue
- ATOS N/A
- BFIN $55,748,000.00
- Revenue This Year
- ATOS N/A
- BFIN N/A
- Revenue Next Year
- ATOS N/A
- BFIN $3.79
- P/E Ratio
- ATOS N/A
- BFIN $17.75
- Revenue Growth
- ATOS N/A
- BFIN N/A
- 52 Week Low
- ATOS $0.62
- BFIN $8.31
- 52 Week High
- ATOS $2.31
- BFIN $12.56
- Technical
- Relative Strength Index (RSI)
- ATOS 54.46
- BFIN 52.93
- Support Level
- ATOS $1.40
- BFIN $11.65
- Resistance Level
- ATOS $1.58
- BFIN $12.05
- Average True Range (ATR)
- ATOS 0.08
- BFIN 0.30
- MACD
- ATOS -0.00
- BFIN -0.01
- Stochastic Oscillator
- ATOS 52.17
- BFIN 44.64
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary innovative medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About BFIN BankFinancial Corporation
BankFinancial Corp is a national bank principally engaged in the business of commercial, family and personal banking. It offers customers a broad range of loan, deposit, trust and other financial products and services. The Bank offers customers a broad range of loan, deposit, trust and other financial products and services through all full-service banking offices located in Cook, DuPage, Lake and Will Counties, Illinois and through Internet Branch.